Retrospective matched-pairs analysis of bortezomib plus dexamethasone versus bortezomib monotherapy in relapsed multiple myeloma

Bortezomib-dexamethasone is widely used for relapsed myeloma in routine clinical practice, but comparative data versus single-agent bortezomib are lacking. This retrospective analysis compared second-line treatment with bortezomib-dexamethasone and bortezomib using 109 propensity score-matched pairs...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Haematologica
Autors principals: Dimopoulos, Meletios A., Orlowski, Robert Z., Facon, Thierry, Sonneveld, Pieter, Anderson, Kenneth C., Beksac, Meral, Benboubker, Lotfi, Roddie, Huw, Potamianou, Anna, Couturier, Catherine, Feng, Huaibao, Ataman, Ozlem, van de Velde, Helgi, Richardson, Paul G.
Format: Artigo
Idioma:Inglês
Publicat: Ferrata Storti Foundation 2015
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4281322/
https://ncbi.nlm.nih.gov/pubmed/25261096
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2014.112037
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars